The eye maintains its shape and function through a continuous flow of fluid called aqueous humor, which is produced inside the eye and drains through a structure known as the iridocorneal angle. In dogs affected by POAG-5, genetic mutations impair the normal function of this drainage pathway. Over time, fluid outflow becomes restricted, leading to a slow but progressive buildup of pressure inside the eye. This increased pressure places stress on the optic nerve, which transmits visual signals from the eye to the brain. Prolonged pressure results in irreversible nerve damage and vision impairment.
Clinical signs of POAG-5 often develop gradually, making early detection challenging without screening. In the initial stages, dogs may show mild or subtle symptoms such as intermittent eye redness, slight discomfort, increased blinking, or watery eyes. As intraocular pressure rises, more noticeable signs may appear, including corneal cloudiness, pupil dilation, reduced responsiveness to visual cues, and behavioral changes such as hesitation in unfamiliar environments or bumping into objects. In advanced stages, the eye may enlarge (buphthalmos), and complete blindness can occur due to optic nerve destruction.
The POAG-5 DNA Health Test is designed to detect the specific genetic mutation associated with this form of Primary Open Angle Glaucoma. Testing is simple, safe, and non-invasive, typically performed using a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Since DNA remains unchanged throughout life, testing can be performed at any age, including before clinical symptoms appear.
Results are generally reported in three categories:
- Clear (Normal): The dog does not carry the POAG-5 mutation and is not expected to develop this genetic form of glaucoma or pass it to offspring.
- Carrier: The dog carries one copy of the mutation and may not show clinical signs, but can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and has a significantly increased likelihood of developing Primary Open Angle Glaucoma (POAG-5).
Genetic testing for POAG-5 is highly valuable for breeders, veterinarians, and dog owners. Breeders can use results to make informed mating decisions that reduce the prevalence of inherited glaucoma while preserving healthy genetic diversity within the breed population. Avoiding carrier-to-carrier pairings significantly reduces the risk of producing affected puppies.
For dog owners, understanding genetic status allows for proactive eye health monitoring and early veterinary intervention. Dogs identified as at risk should receive regular ophthalmic examinations to monitor intraocular pressure and detect early changes. While there is no cure for optic nerve damage caused by glaucoma, early treatment with pressure-lowering medications, laser therapy, or surgical options can help slow progression and preserve vision for as long as possible.
The Primary Open Angle Glaucoma (POAG-5) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine ocular health, and helps reduce the impact of this inherited cause of blindness in future generations.
